7th Symposium

Oral communications session 1
Oral Communications


Jose A. Muñoz-Moreno, Ph.D.

Lluita contra les Infeccions Foundation, Germans Trias i Pujol University Hospital. Barcelona, Spain

Jose A. Muñoz-Moreno is a clinician and researcher at the Lluita contra les Infeccions Foundation, located in the Germans Trias i Pujol University Hospital, in Barcelona (Catalonia, Spain). He earned the Ph.D. degree in Neurosciences in 2012 (Cum Laude), and currently he is also a collaborating professor with the Universitat de Barcelona (UB) and the Universitat Autònoma de Barcelona (UAB).

Muñoz-Moreno is involved in projects that address psychology and the human behaviour associated with HIV infection. In terms of study, he mostly investigates the neurocognitive features of HIV infection, the impact of HIV and antiretroviral treatments on quality of life and emotional status, and adherence to antiretroviral therapy.

Muñoz-Moreno’s recent work particularly focuses on assessment methods to detect HIV-related neurocognitive changes and the current profile of neurocognitive impairment in people living with HIV infection.

Read More

Accuracy of the NEU Screen for Detecting Neurocognitive Impairment in Virologically Supressed Patiens with HIV Infection

Nadezda Apostolova, M.D.

Department of Pharmacology, Faculty of Health Sciences, Universitat Jaume I. Castellón, Spain.

Read More

Efavirenz increases nitric oxide production in glia cells but not in neurons

Daniel Podzamczer, M.D.

HIV and STI Unit, Infectious Diseases Service, Bellvitge University Hospital–IDIBELL. Barcelona, Spain.

Read More

DRV concentrations and viral load in CSF in pts on DRV/r 600/100 or 800/100mg once daily plus two NRTI

David Moore, Ph. D.

HIV Neurobehavioral Research Program (HNRP). University of California San Diego. USA

Dr. Moore is a licensed clinical psychologist and an Associate Professor conducting research at the HIV Neurobehavioral Research Program (HNRP). He focuses on neurocognitive impairment and daily functioning difficulty among persons with co-occurring HIV infection, serious mental illness, and substance use disorders. He has a particularly interest in technological interventions to improve medication adherence. Dr. Moore is also a faculty member of the SDSU/UCSD Joint Doctoral Program in Clinical Psychology.

Read More

Lower Levels of Moderate Physical Activity are Associated with neurocognitive Impairment among Older HIV + Adults

Giovanni Guaraldi, M.D.

Infectious Disease, University of Modena and Reggio Emilia. Italy

He is a member of the special Task Force of the Chancellor of the University of Modena and Reggio Emilia, in Modena, Italy dedicated to developing international cooperation in reseach. As such he has acquired extensive experience in dealing with issues related to the care of HIV patients in resource-limited Countries.
In 2002 he started a liver and kidney transplant program for HIV infected patients at the multi-organ transplant centre at Policlinico of Modena. He personally cares for approximately 80 HIV patients who received solid organ transplantation.
Since the year 2000 he leads the Modena HIV Metabolic Clinic (MHMC). This referral centre offers a multidisciplinary team approach to HIV patients with metabolic abnormalities and offers a multidimensional evaluation of ageing HIV infected patients. More than 4500 patients are followed at this Centre.

Read More

Aging well with HIV infection: beyond the absence of comodities